Shane Kovacs
2023 - Olema Pharmaceuticals
In 2023, Shane Kovacs earned a total compensation of $1.5M as Chief Operating and Financial Officer at Olema Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $286,000 |
|---|---|
| Option Awards | $728,000 |
| Salary | $520,000 |
| Other | $14,370 |
| Total | $1,548,370 |
Kovacs received $728K in option awards, accounting for 47% of the total pay in 2023.
Kovacs also received $286K in non-equity incentive plan, $520K in salary and $14.4K in other compensation.
Rankings
In 2023, Shane Kovacs' compensation ranked 700th out of 2,297 executives tracked by ExecPay. In other words, Kovacs earned more than 69.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 700 out of 2,297 | 70th |
Division Manufacturing | 399 out of 1,247 | 68th |
Major group Chemicals And Allied Products | 274 out of 705 | 61st |
Industry group Drugs | 269 out of 676 | 60th |
Industry Pharmaceutical Preparations | 182 out of 490 | 63rd |
Source: SEC filing on April 26, 2024.
Kovacs' colleagues
We found three more compensation records of executives who worked with Shane Kovacs at Olema Pharmaceuticals in 2023.